Multi-omics Study of Systemic Sclerosis Immunoglobulins G Effects on Endothelial Cells: A Distinct Profile in Anti-Topoisomerase I Positive Patients

被引：0
|
作者：
Chepy, Aurelien [1 ]
Vivier, Solange [1 ]
Elhannani, Abderrahmane [1 ]
Bray, Fabrice [2 ]
Chauvet, Clement [1 ]
Figeac, Martin [3 ]
Guilbert, Lucile [1 ]
Hachulla, Eric [4 ]
Rolando, Christian [2 ]
Dubucquoi, Sylvain [1 ]
Launay, David [1 ]
Sobanski, Vincent [1 ]
机构：
[1] Univ Lille, Inserm, CHU Lille, INFINITE Inst Translat Res Inflammat,U1286, F-59000 Lille, Nord Pas De Cal, France
[2] Univ Lille, CNRS, USR 3290, MSAP Miniaturisat Synth Anal & Prote, F-59000 Lille, France
[3] Univ Lille, CNRS, Inst Pasteur Lille, Inserm,CHU Lille,US 41,UAR2014,PLBS, F-59000 Lille, France
[4] CHU Lille, Dept Med Interne & Immunol Clin, Ctr Reference Malad Autoimmunes System Rares Nord, Lille, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0961
引用
收藏
页码：1984 / 1986
页数：3
相关论文
共 37 条
  • [21] The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis
    Radic, M.
    Kaliterna, D. Martinovic
    Ljutic, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (04) : 407 - 412
  • [22] Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody
    Perera, Achini
    Fertig, Noreen
    Lucas, Mary
    Rodriguez-Reyna, Tatiana S.
    Hu, Paul
    Steen, Virginia D.
    Medsger, Thomas A., Jr.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (08): : 2740 - 2746
  • [23] The level of anti-topoisomerase I antibodies correlates with the severity of metacarpophalaingeal and proximal nterphalangeal joints flexion contractures in patients with systemic sclerosis
    Radic, M.
    Kaliterna, D. Martinovic
    Ljutic, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 221 - 221
  • [24] Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease
    Ebata, Satoshi
    Yoshizaki, Ayumi
    Fukasawa, Takemichi
    Miura, Shunsuke
    Takahashi, Takehiro
    Sumida, Hayakazu
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2019, 46 (11): : 1006 - 1013
  • [25] Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation
    Glaeser, L.
    Henes, J.
    Koetter, I.
    Vogel, W.
    Kanz, L.
    Klein, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : S28 - S35
  • [26] Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis
    Gourh, Pravitt
    Tan, Filemon K.
    Assassi, Shervin
    Ahn, Chul W.
    McNearney, Terry A.
    Fischbach, Michael
    Arnett, Frank C.
    Mayes, Maureen D.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 3945 - 3953
  • [27] Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti-topoisomerase I antibody
    Hamaguchi, Yasuhito
    Yoshimura, Yukari
    Horii, Motoki
    Fushida, Natsumi
    Kitano, Tasuku
    Sawada, Kaori
    Oishi, Kyosuke
    Maeda, Shintaro
    Watanabe, Satoshi
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGY, 2024, 51 (01): : 62 - 69
  • [28] IGG from patients with diffuse systemic sclerosis (SSC) with or without anti-topoisomerase 1 (anti-topo 1) antibodies express distinct reactivity profiles with normal human fibroblasts antigens
    Tamby, MC
    Servettaz, A
    Chanseaud, YA
    Guilpain, R
    Allanore, Y
    Kahan, A
    Meyer, O
    Guillevin, L
    Mouthon, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 347 - 348
  • [29] Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain
    Ueki, A
    Isozaki, Y
    Tomokuni, A
    Ueki, H
    Kusaka, M
    Tanaka, S
    Otsuki, T
    Sakaguchi, H
    Hyodoh, F
    IMMUNOBIOLOGY, 2001, 204 (04) : 458 - 465
  • [30] Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial
    Mayes, Maureen
    Highland, Kristin
    Gahlemann, Martina
    Raghu, Ganesh
    Girard, Mannaig
    Matucci-Cerinic, Marco
    Volkmann, Elizabeth
    Kuwana, M.
    Alves, Margardia
    Stowasser, Susanne
    Distler, Joerg
    Distler, Oliver
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1085 - 1085
1234